Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Encouraging early results with GS-9973 for CLL and NHL

Dr Jeff Sharman- US Oncology, Eugene, Oregon
Encouraging early results with GS-9973 for CLL and NHL ( Dr Jeff Sharman- US Oncology, Eugene, Oregon )
18 Dec 2013

Benefit of lenalidomide and low-dose dexamethasone over standard therapy for multiple myeloma

Dr Thierry Facon - Centre Hospitalier Régional Universitaire de Lille, Lille, France
Benefit of lenalidomide and low-dose dexamethasone over standard therapy for multiple myeloma ( Dr Thierry Facon - Centre Hospitalier Régional Universitaire de Lille, Lille, France )
18 Dec 2013

Gemtuzumab improves event free survival for paediatric acute myeloid leukaemia (AML)

Dr Alan Gamis - University of Missouri-Kansas City School of Medicine, USA
Gemtuzumab improves event free survival for paediatric acute myeloid leukaemia (AML) ( Dr Alan Gamis - University of Missouri-Kansas City School of Medicine, USA )
17 Dec 2013

PIK3CA gene mutations make HER2- and hormone receptor-positive breast cancers treatment-resistant

Prof Sibylle Loibl - German Breast Group, Neu-Isenburg, Germany
PIK3CA gene mutations make HER2- and hormone receptor-positive breast cancers treatment-resistant ( Prof Sibylle Loibl - German Breast Group, Neu-Isenburg, Germany )
16 Dec 2013

Avoiding radiotherapy is an option for some older patients with breast cancer

Prof Ian Kunkler - University of Edinburgh, Edinburgh, UK
Avoiding radiotherapy is an option for some older patients with breast cancer ( Prof Ian Kunkler - University of Edinburgh, Edinburgh, UK )
16 Dec 2013

New agents in CLL

Dr Jacqueline Barrientos - LIJ Medical Center, New York, USA
New agents in CLL ( Dr Jacqueline Barrientos - LIJ Medical Center, New York, USA )
13 Dec 2013

Chronic lymphocytic leukaemia: A new treatment era is born

Dr John Gribben - Barts Cancer Institute, London, UK
Chronic lymphocytic leukaemia: A new treatment era is born ( Dr John Gribben - Barts Cancer Institute, London, UK )
13 Dec 2013

2013 ecancer highlights

Prof Gordon McVie - ecancer and European Institute of Oncology
2013 ecancer highlights ( Prof Gordon McVie - ecancer and European Institute of Oncology )
11 Dec 2013

Patient information needs in biomarkers and biobanking

Francesco de Lorenzo - President of ECPC; Kathi Apostolidis - Vice President of ECPC; George Stamatis - Vice President of KEFI; Dr Pauline Evers - Nederlanse Federatie van Kankerpatienteorganisaties
Patient information needs in biomarkers and biobanking ( Francesco de Lorenzo - President of ECPC; Kathi Apostolidis - Vice President of ECPC; George Stamatis - Vice President of KEFI; Dr Pauline Evers - Nederlanse Federatie van Kankerpatienteorganisaties )
4 Dec 2013

Cancer cells and the immune system: a natural story?

Prof. Laurence Zitvogel - INSERM, Institut Gustave Roussy, Villejuif, France
Cancer cells and the immune system: a natural story? ( Prof. Laurence Zitvogel - INSERM, Institut Gustave Roussy, Villejuif, France )
3 Dec 2013

Immuno-Oncology: the next new paradigm in cancer treatment? Chairman's welcome and introduction

Prof. Winald Gerritsen - Radboud University Nijmegen Medical Centre, The Netherlands
Immuno-Oncology: the next new paradigm in cancer treatment? Chairman's welcome and introduction ( Prof. Winald Gerritsen - Radboud University Nijmegen Medical Centre, The Netherlands )
3 Dec 2013

Why are Immuno-Oncology compounds different?

Prof. Enriqueta Felip - Vall d'Hebron University Hospital, Barcelona, Spain
Why are Immuno-Oncology compounds different? ( Prof. Enriqueta Felip - Vall d'Hebron University Hospital, Barcelona, Spain )
3 Dec 2013